Axsome Therapeutics, Inc. Tech Stack

Biopharmaceutical company developing CNS therapies for underserved conditions

Biotechnology Research New York, NY 201–500 employees Founded 2012 Public Company

Axsome is a public biotech company focused on CNS disorders with limited treatment options, currently executing launches and scaling commercial operations across pain, depression, narcolepsy, and other neurological indications. The hiring mix is heavily weighted toward sales (356 roles) relative to research and engineering, reflecting a mature commercial-stage business navigating payer access and physician adoption rather than a discovery-focused org. Active projects center on product launches (Auvelity for major depressive disorder), territory expansion, and payer engagement — pain points cluster around clinic access, prescriber adoption, and competitive positioning in crowded markets.

Tech Stack 15 technologies

Core StackTableau Power BI Python AWS SharePoint IQVIA SQL Micros Microsoft Office Excel PowerPoint Word R Salesforce Marketing Cloud HTML

What Axsome Therapeutics, Inc. Is Building

◆Challenges

Launching new product
Gaining access to clinic customers
Access barriers
Promoting new drug in competitive market
Roadblocks for eligible patients
Conversion rates
Increasing prescription rates
Growing prescriber confidence
Navigating payer processes
Accessing customers in clinic or hospital setting

▲Active Projects

Promote auvelity for major depressive disorder
Erp implementation
Promotion of auvelity labeling
Auvelity launch
Territory business plan development
Executing national medical affairs plan
Marketing resource optimization
Developing the ada franchise
Payer engagement strategy
Peer to peer speaker development

Hiring Activity

Decelerating420 roles · 75 in 30d

Department

Sales

356

Healthcare

Marketing

Data

Finance

Research

Engineering

Legal

Seniority

Mid

307

Director

Senior

Manager

Intern

Junior

Notable leadership hires: Business Director, National Business Director, Regional Business Director

Company intelligence

Find more companies like Axsome Therapeutics, Inc. by tech stack, pain points and active projects

Get started free

About Axsome Therapeutics, Inc.

Axsome Therapeutics is a publicly traded biopharmaceutical company headquartered in New York, founded in 2012, with 201–500 employees across the United States, Canada, and Argentina. The company develops novel therapies targeting central nervous system conditions including major depressive disorder, pain syndromes, narcolepsy, fibromyalgia, migraine, ADHD, smoking cessation, and Alzheimer's disease agitation. Operations span clinical development, regulatory approval, and commercial launch; the organization uses BI tools (Tableau, Power BI), Salesforce for marketing, and SQL/Python for analytics. Current focus includes launching Auvelity and expanding the ADA franchise into new indications while managing payer relationships and building prescriber networks.

HeadquartersNew York, NY

Company Size201–500 employees

Founded2012

Hiring MarketsUnited States, Argentina, Canada

Frequently Asked Questions

What is Axsome Therapeutics working on?

Axsome is executing launches of Auvelity for major depressive disorder, developing the ADA franchise, building payer engagement strategies, and scaling physician outreach through territory business plans and speaker development programs.

What tech stack does Axsome use?

Axsome uses SharePoint, IQVIA, Tableau, Power BI, SQL, Python, Salesforce Marketing Cloud, AWS, and Microsoft Office suite. No major tech replacements are currently underway.